Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid...
Uloženo v:
| Vydáno v: | World journal of gastroenterology : WJG Ročník 26; číslo 38; s. 5759 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
14.10.2020
|
| Témata: | |
| ISSN: | 2219-2840, 2219-2840 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid tumors like HCC are complex and have heterogeneous tumor genomic profiles contributing to complexity in diagnosis and management. Chronic infection with hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) are the greatest etiological risk factors for HCC. Due to the significant role of chronic viral infection in HCC development, it is important to investigate direct (viral associated) and indirect (immune-associated) mechanisms involved in the pathogenesis of HCC. Common mechanisms used by HBV, HCV, and HDV that drive hepatocarcinogenesis include persistent liver inflammation with an impaired antiviral immune response, immune and viral protein-mediated oxidative stress, and deregulation of cellular signaling pathways by viral proteins. DNA integration to promote genome instability is a feature of HBV infection, and metabolic reprogramming leading to steatosis is driven by HCV infection. The current review aims to provide a brief overview of HBV, HCV and HDV molecular biology, and highlight specific viral-associated oncogenic mechanisms and common molecular pathways deregulated in HCC, and current as well as emerging treatments for HCC. |
|---|---|
| AbstractList | Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid tumors like HCC are complex and have heterogeneous tumor genomic profiles contributing to complexity in diagnosis and management. Chronic infection with hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) are the greatest etiological risk factors for HCC. Due to the significant role of chronic viral infection in HCC development, it is important to investigate direct (viral associated) and indirect (immune-associated) mechanisms involved in the pathogenesis of HCC. Common mechanisms used by HBV, HCV, and HDV that drive hepatocarcinogenesis include persistent liver inflammation with an impaired antiviral immune response, immune and viral protein-mediated oxidative stress, and deregulation of cellular signaling pathways by viral proteins. DNA integration to promote genome instability is a feature of HBV infection, and metabolic reprogramming leading to steatosis is driven by HCV infection. The current review aims to provide a brief overview of HBV, HCV and HDV molecular biology, and highlight specific viral-associated oncogenic mechanisms and common molecular pathways deregulated in HCC, and current as well as emerging treatments for HCC. Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid tumors like HCC are complex and have heterogeneous tumor genomic profiles contributing to complexity in diagnosis and management. Chronic infection with hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) are the greatest etiological risk factors for HCC. Due to the significant role of chronic viral infection in HCC development, it is important to investigate direct (viral associated) and indirect (immune-associated) mechanisms involved in the pathogenesis of HCC. Common mechanisms used by HBV, HCV, and HDV that drive hepatocarcinogenesis include persistent liver inflammation with an impaired antiviral immune response, immune and viral protein-mediated oxidative stress, and deregulation of cellular signaling pathways by viral proteins. DNA integration to promote genome instability is a feature of HBV infection, and metabolic reprogramming leading to steatosis is driven by HCV infection. The current review aims to provide a brief overview of HBV, HCV and HDV molecular biology, and highlight specific viral-associated oncogenic mechanisms and common molecular pathways deregulated in HCC, and current as well as emerging treatments for HCC.Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the third leading cause of cancer-associated mortality, of which hepatocellular carcinoma (HCC) represents 90% of all primary liver cancers. Solid tumors like HCC are complex and have heterogeneous tumor genomic profiles contributing to complexity in diagnosis and management. Chronic infection with hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) are the greatest etiological risk factors for HCC. Due to the significant role of chronic viral infection in HCC development, it is important to investigate direct (viral associated) and indirect (immune-associated) mechanisms involved in the pathogenesis of HCC. Common mechanisms used by HBV, HCV, and HDV that drive hepatocarcinogenesis include persistent liver inflammation with an impaired antiviral immune response, immune and viral protein-mediated oxidative stress, and deregulation of cellular signaling pathways by viral proteins. DNA integration to promote genome instability is a feature of HBV infection, and metabolic reprogramming leading to steatosis is driven by HCV infection. The current review aims to provide a brief overview of HBV, HCV and HDV molecular biology, and highlight specific viral-associated oncogenic mechanisms and common molecular pathways deregulated in HCC, and current as well as emerging treatments for HCC. |
| Author | Patel, Trushar R D'souza, Simmone Lau, Keith Ck Coffin, Carla S |
| Author_xml | – sequence: 1 givenname: Simmone surname: D'souza fullname: D'souza, Simmone organization: Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary T2N 1N4, AB, Canada – sequence: 2 givenname: Keith Ck surname: Lau fullname: Lau, Keith Ck organization: Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary T2N 1N4, AB, Canada – sequence: 3 givenname: Carla S surname: Coffin fullname: Coffin, Carla S organization: Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary T2N 1N4, AB, Canada – sequence: 4 givenname: Trushar R surname: Patel fullname: Patel, Trushar R organization: Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary T2N 1N4, AB, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33132633$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNTztPwzAYtFARfcDOhDKyJNj-YscZUQUUqYile_TFdqirOC5xUsS_59EiMd3pdHe6m5NJFzpLyDWjGRS5uvvYvWUHLjMHKhOFKM_IjHNWplzldPKPT8k8xh2lHEDwCzIFYMAlwIysXkJr9dhin3irt9i56GMSmuTgemyTrd3j4AYXE9eZUVtzVIK2bfsb0thr1wWPl-S8wTbaqxMuyObxYbNcpevXp-fl_TrVueRDanJqcq2MZqxpykI3hdLCsFoUtTYgBQKvJRoorWS6VGWtAJVligpKC4p8QW6Ptfs-vI82DpV38WcNdjaMseK5kEoIEPTbenOyjrW3ptr3zmP_Wf2d51-BY18l |
| CitedBy_id | crossref_primary_10_1155_2022_1964866 crossref_primary_10_1097_MEG_0000000000002857 crossref_primary_10_3389_fimmu_2023_1210802 crossref_primary_10_3389_fcell_2021_690882 crossref_primary_10_3389_fimmu_2024_1402135 crossref_primary_10_1007_s00103_021_03482_y crossref_primary_10_3389_fimmu_2022_984728 crossref_primary_10_1016_j_hlife_2024_03_004 crossref_primary_10_3390_microorganisms9051073 crossref_primary_10_1002_ijc_34935 crossref_primary_10_3390_v13071333 crossref_primary_10_3390_ijms231810862 crossref_primary_10_3390_ijms26167836 crossref_primary_10_3390_cancers15072104 crossref_primary_10_1016_j_bbrc_2024_150876 crossref_primary_10_3390_pathogens10111366 crossref_primary_10_1155_2021_1205029 crossref_primary_10_1155_2022_8755263 crossref_primary_10_1016_j_canlet_2024_217061 crossref_primary_10_1016_j_micpath_2023_106292 crossref_primary_10_1186_s12885_022_09465_9 crossref_primary_10_1002_ctm2_70306 crossref_primary_10_1007_s12072_022_10457_x crossref_primary_10_1038_s41598_024_74138_5 crossref_primary_10_52711_0974_360X_2024_00423 crossref_primary_10_3389_fimmu_2023_1046771 crossref_primary_10_1177_10732748241310573 crossref_primary_10_1177_1934578X241284873 crossref_primary_10_3389_fonc_2023_1185142 crossref_primary_10_1111_liv_15253 crossref_primary_10_2152_jmi_72_47 crossref_primary_10_2174_0115665240284347240125072555 crossref_primary_10_3390_cancers13225867 crossref_primary_10_1016_j_bcp_2023_115740 crossref_primary_10_3390_ijms22157961 crossref_primary_10_3389_fmicb_2023_1213145 crossref_primary_10_1016_j_asjsur_2023_02_056 crossref_primary_10_3389_fmolb_2021_676957 crossref_primary_10_3390_biomedicines11010231 crossref_primary_10_1080_17474124_2021_1900732 crossref_primary_10_1016_j_gene_2023_147467 crossref_primary_10_48130_git_0025_0007 crossref_primary_10_1016_j_intimp_2021_107790 crossref_primary_10_3748_wjg_v27_i24_3466 crossref_primary_10_3389_fgene_2022_937310 crossref_primary_10_1007_s11901_024_00664_5 crossref_primary_10_1111_cbdd_14428 crossref_primary_10_3390_cells12060869 crossref_primary_10_3390_ijms23158711 crossref_primary_10_1016_j_biopha_2023_115578 crossref_primary_10_7759_cureus_72239 crossref_primary_10_1016_j_canep_2023_102457 crossref_primary_10_3390_jpm13030397 crossref_primary_10_1111_cas_15357 crossref_primary_10_3390_microorganisms12071482 crossref_primary_10_1080_02648725_2023_2216072 crossref_primary_10_1016_j_virol_2024_110273 crossref_primary_10_3389_fphar_2024_1433540 crossref_primary_10_1007_s10528_023_10527_1 crossref_primary_10_1007_s10142_024_01519_4 crossref_primary_10_1016_j_ygeno_2024_110831 crossref_primary_10_3390_ijms241814404 crossref_primary_10_1002_jmv_29692 crossref_primary_10_1186_s13148_023_01508_7 crossref_primary_10_3389_fendo_2025_1548924 crossref_primary_10_3390_cancers16112042 crossref_primary_10_1111_liv_15624 crossref_primary_10_1002_ctd2_70063 crossref_primary_10_4081_itjm_2023_1626 crossref_primary_10_3390_v17091159 crossref_primary_10_1016_j_critrevonc_2024_104264 crossref_primary_10_3389_fonc_2021_677926 crossref_primary_10_3389_fphar_2022_1029601 crossref_primary_10_3389_fimmu_2023_1141956 crossref_primary_10_2147_IJGM_S462844 crossref_primary_10_1016_j_addr_2022_114114 crossref_primary_10_1097_MD_0000000000028837 crossref_primary_10_2147_JHC_S307962 crossref_primary_10_1038_s41392_022_01194_6 crossref_primary_10_1155_2022_6213865 crossref_primary_10_1002_jmv_70239 crossref_primary_10_3390_cancers16081505 crossref_primary_10_3390_v13081572 crossref_primary_10_3390_ijms21249644 crossref_primary_10_1007_s00432_023_05291_z crossref_primary_10_1016_j_aohep_2021_100649 crossref_primary_10_1016_j_heliyon_2024_e24437 crossref_primary_10_1016_j_tranon_2023_101656 crossref_primary_10_1080_15592294_2023_2276371 crossref_primary_10_1007_s11864_023_01098_9 crossref_primary_10_2147_IJN_S399146 crossref_primary_10_1038_s41598_023_34117_8 crossref_primary_10_3390_cancers15020533 crossref_primary_10_3389_fimmu_2025_1595638 crossref_primary_10_3390_cancers14112700 crossref_primary_10_3389_fmicb_2023_1280210 crossref_primary_10_3390_ijms22179380 crossref_primary_10_3390_pharmaceutics15082138 crossref_primary_10_7759_cureus_83681 crossref_primary_10_3389_fcell_2023_1194199 crossref_primary_10_1016_j_toxicon_2025_108576 crossref_primary_10_3390_ijms22031224 crossref_primary_10_3390_livers5010001 crossref_primary_10_3390_cells10113091 crossref_primary_10_3390_diseases13070207 crossref_primary_10_3390_biomedicines12020299 crossref_primary_10_3390_ijms231911188 crossref_primary_10_3748_wjg_v28_i25_2823 crossref_primary_10_3892_ol_2023_14034 crossref_primary_10_1136_gutjnl_2021_324915 crossref_primary_10_3389_fphar_2023_1225821 crossref_primary_10_1016_j_meegid_2025_105777 crossref_primary_10_1093_gastro_goae057 crossref_primary_10_1186_s12964_024_01622_w crossref_primary_10_3389_fonc_2022_913231 crossref_primary_10_1007_s00432_023_05474_8 crossref_primary_10_1007_s12033_023_01025_1 crossref_primary_10_1080_10408398_2025_2451761 crossref_primary_10_3389_fimmu_2024_1479505 crossref_primary_10_3390_pathogens14080828 crossref_primary_10_1007_s12672_025_03320_6 crossref_primary_10_1016_S2468_1253_22_00041_3 crossref_primary_10_3390_pathogens14030258 crossref_primary_10_3389_fmed_2024_1521851 crossref_primary_10_3389_fimmu_2022_978190 crossref_primary_10_1016_j_heliyon_2024_e27322 crossref_primary_10_1038_s41392_025_02197_9 crossref_primary_10_1093_jb_mvab088 crossref_primary_10_12998_wjcc_v9_i19_4890 crossref_primary_10_1016_j_ijid_2023_01_036 crossref_primary_10_3389_fcell_2025_1537731 crossref_primary_10_1002_hep_32738 crossref_primary_10_1113_JP283074 crossref_primary_10_18699_SSMJ20250101 crossref_primary_10_3390_cancers15215178 crossref_primary_10_1080_07391102_2025_2517826 crossref_primary_10_3390_v14050986 crossref_primary_10_32604_biocell_2024_050396 crossref_primary_10_1007_s12672_025_03123_9 crossref_primary_10_1055_a_1913_8223 crossref_primary_10_3390_biomedicines11041166 crossref_primary_10_1002_pdi3_29 crossref_primary_10_1016_j_ecoenv_2024_117437 crossref_primary_10_3390_cancers13102485 crossref_primary_10_1186_s13027_022_00471_x crossref_primary_10_3390_ijms251910233 crossref_primary_10_3390_nu13114071 crossref_primary_10_1016_j_intimp_2024_112097 crossref_primary_10_1080_14786419_2024_2384083 crossref_primary_10_3389_fimmu_2024_1332818 crossref_primary_10_3390_cancers14235742 crossref_primary_10_1007_s00210_024_02980_5 crossref_primary_10_1007_s00210_025_03861_1 crossref_primary_10_1080_21655979_2021_2017629 crossref_primary_10_1097_QAD_0000000000003022 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Copyright_xml | – notice: The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.3748/wjg.v26.i38.5759 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 2219-2840 |
| ExternalDocumentID | 33132633 |
| Genre | Journal Article Review |
| GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 8WL AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CGR CHBEP CIEJG CS3 CUY CVF CW9 DIK DU5 E3Z EBS ECM EIF EJD F5P FA0 FRP GX1 HYE NPM OK1 P2P RNS RPM TR2 XSB 7X8 |
| ID | FETCH-LOGICAL-c462t-d40d4c8dc11ff97cf78c5d1b57bcd365a32b6ad39e61c989b83a8e18050070a2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 181 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000586370900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2219-2840 |
| IngestDate | Thu Jul 10 19:54:47 EDT 2025 Thu Apr 03 07:09:34 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 38 |
| Keywords | Hallmarks of cancer Viral hepatitis Hepatitis delta virus co-infection Molecular mechanisms Hepatocellular carcinoma Hepatitis B virus Hepatitis C virus Chronic viral infection |
| Language | English |
| License | The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-d40d4c8dc11ff97cf78c5d1b57bcd365a32b6ad39e61c989b83a8e18050070a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/7579760 |
| PMID | 33132633 |
| PQID | 2456855350 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2456855350 pubmed_primary_33132633 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-Oct-14 20201014 |
| PublicationDateYYYYMMDD | 2020-10-14 |
| PublicationDate_xml | – month: 10 year: 2020 text: 2020-Oct-14 day: 14 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationTitleAlternate | World J Gastroenterol |
| PublicationYear | 2020 |
| SSID | ssj0023352 |
| Score | 2.6564472 |
| SecondaryResourceType | review_article |
| Snippet | Chronic infection with viral hepatitis affects half a billion individuals worldwide and can lead to cirrhosis, cancer, and liver failure. Liver cancer is the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 5759 |
| SubjectTerms | Carcinoma, Hepatocellular Hepatitis B - complications Hepatitis B virus - genetics Hepatitis, Viral, Human Humans Liver Neoplasms |
| Title | Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33132633 https://www.proquest.com/docview/2456855350 |
| Volume | 26 |
| WOSCitedRecordID | wos000586370900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwEK_yUpBYXRK_MyGEqLq06tChW-RXoIgmhZTy9_ElKUxISCweLJ10OvvO9_J9CN0QlhNrYoaFzjlmXMugUtxgRgPbwoUIwdkabEKORmo6Tcdtwq1q2yrXNrE21K60kCO_hQKd4pzy-G7xhgE1CqqrLYTGJurQ4MpAS5ecflcRCPwnAnC5oJU4mOG4KVPCwJXbz5en3oqI3oyqHmBU_u5g1g9Nf--_LO6j3dbFjO6bO3GANnxxiAbDNQ5uNPfw23dWzauozCNo8n2Nnj10Vi9nVRRi9HDartkpIa9fE1nAHCrKuT5Ck_7j5GGAWxQFbJkgS-xY7JhVziZJnqcwhUhZ7hLDpbGOCq4pMUI7mnqR2FSlRlGtfKJiDqOANDlGW0VZ-FMUmdiZ2GsiqLXMSW1SJQKRllJ7Fzy_LrpeyyULlxQ41IUvP6rsRzJddNIIN1s00zQyCsMjBaVnf6A-RzsE4l3oKGEXqJMHFfWXaNuugoDer-rTD-toPPwCwA-7vQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mechanisms+of+viral+hepatitis+induced+hepatocellular+carcinoma&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=D%27souza%2C+Simmone&rft.au=Lau%2C+Keith+Ck&rft.au=Coffin%2C+Carla+S&rft.au=Patel%2C+Trushar+R&rft.date=2020-10-14&rft.eissn=2219-2840&rft.volume=26&rft.issue=38&rft.spage=5759&rft_id=info:doi/10.3748%2Fwjg.v26.i38.5759&rft_id=info%3Apmid%2F33132633&rft_id=info%3Apmid%2F33132633&rft.externalDocID=33132633 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2219-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2219-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2219-2840&client=summon |